Tissue distribution and pulmonary targeting studies of cefpiramide sodium-loaded liposomes

Journal of Drug Targeting

Volumn 19, Issue 1, 2011, Pages 49-55

  Sun, Qingxue ^a   Shi, Ming ^b   Shao, Wei ^a   Shi, Yang ^a   Xi, Yanwei ^a   Huang, Guihua ^a  

^a SHANDONG UNIVERSITY   (China)

^b Jining First People's Hospital   (China)

Author keywords

biodistribution; Liposomes; lung targeting; pharmacokinetics

Indexed keywords

CEFPIRAMIDE; LIPOSOME;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TARGETING; EVAPORATION; FEMALE; LIQUID LIQUID EXTRACTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; FEMALE; INJECTIONS, INTRAVENOUS; LIPOSOMES; LUNG; MALE; MICE; TISSUE DISTRIBUTION;

EID: 78650070623     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003667607     Document Type: Article

References (16)

1. Barratt G. (2003). Colloidal drug carriers: Achievements and perspectives. Cell Mol Life Sci, 60, 21-37.
2. Chen ZG, Zhen JC, Zhang TH. (2000). Determination of cefpiramide in human serum and urine by HPLC. J Chin Pharm, 35, 765-767.
3. Fekety FR. (1990). Safety of parenteral third-generation cephalosporins. Am J Med, 88, 38S-44S.
4. Júnior AD, Mota LG, Nunan EA, Wainstein AJ, Wainstein AP, Leal AS, Cardoso VN, De Oliveira MC. (2007). Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor-bearing mice. Life Sci, 80, 659-664.
5. Muraoka I, Hasegawa T, Nadai M, Wang L, Haghgoo S, Tagaya O, Nabeshima T. (1995). Biliary and renal excretions of cefpiramide in Eisai hyperbilirubinemic rats. Antimicrob Agents Chemother, 39, 70-74.
6. Nagayasu A, Uchiyama K, Kiwada H. (1999). The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv Drug Deliv Rev, 40, 75-87.
7. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. (2000). High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science, 288, 1251-1254.
8. Poyner EA, Alpar HO, Almeida AJ, Gamble MD, Brown MRW. (1995). A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery. J Control Release, 35, 41-48.
9. Srinath P, Chary MG, Vyas SP, Diwan PV. (2000). Long-circulating liposomes of indomethacin in arthritic rats-a biodisposition study. Pharm Acta Helv, 74, 399-404.
10. Sun W, Zou W, Huang G, Li A, Zhang N. (2008). Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target, 16, 357-365.
11. Stark B, Andreae F, Mosgoeller W, Edetsberger M, Gaubitzer E, Koehler G, Prassl R. (2008). Liposomal vasoactive intestinal peptide for lung application: Protection from proteolytic degradation. Eur J Pharm Biopharm, 70, 153-164.
12. Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M. (2000). In vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. J Infect Chemother, 6, 81-85.
13. Wang JS, Zhu JB, Lu RQ, Shen W. (2005). Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice. Acta Pharmaceut Sin, 40, 274-278.
14. Westphal JF, Vetter D, Brogard JM. (1994). Hepatic side-effects of antibiotics. J Antimicrob Chemother, 33, 387-401.
15. Wu PC, Tsai YH, Liao CC, Chang JS, Huang YB. (2004). The characterization and biodistribution of cefoxitin-loaded liposomes. Int J Pharm, 271, 31-39.
16. Zhang X, Sun P, Bi R, Wang J, Zhang N, Huang G. (2009). Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation. J Drug Target, 17, 399-407.